Bivalent omicron (BA.1) booster vaccination against SARS-CoV-2

Lancet Infect Dis. 2023 Aug;23(8):880-881. doi: 10.1016/S1473-3099(23)00189-5. Epub 2023 Apr 21.

Authors

Andrey V Vasin¹, Marina A Stukova²

Affiliations

¹ Smorodintsev Research Institute of Influenza, Saint Petersburg, Russia; Institute of Biomedical Systems and Biotechnologies, Peter the Great St Petersburg Polytechnic University, Saint Petersburg, 195251, Russia. Electronic address: vasin_av@spbstu.ru.
² Smorodintsev Research Institute of Influenza, Saint Petersburg, Russia.

No abstract available

Publication types

Comment

MeSH terms

COVID-19* / prevention & control
Humans
Immunization, Secondary
SARS-CoV-2*
Vaccination